Delivery Order SPE2DB24D1205-SPE2DB25FCYCH
Award Date
6/27/25
Potential Completion Date
6/30/25
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of GLIMEPIRIDE 2 MG TABLET 100S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $1,990.05. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999.00, which provides comprehensive global pharmaceutical support to military healthcare...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of GLIMEPIRIDE 2 MG TABLET 100S. The contract has a firm fixed price, with a ceiling value of $1,862.06, and an ultimate completion date of June 24, 2025. The contract is not set-aside and was awarded on June 23, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S, a generic prescription drug, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $4,218.99. The contract has an ultimate completion date of April 3, 2025 and was awarded on April 2, 2025. This contract is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of GLIMEPIRIDE 1 MG TABLET 100S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,138.32 and an ultimate completion date of August 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which serves as the primary...
This federal contract award is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $1,400.55 and is a Firm Fixed Price Delivery Order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $9,286.57, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 21, 2025. This award is not associated with a set-aside designation, indicating open competition....
The U.S. Defense Logistics Agency (DLA) awarded a $2,625.36 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of 4565392018 - GLIMEPIRIDE 2 MG TABLET 500S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the agency to efficiently procure a comprehensive range of medical...
This federal contract award is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 16, 2024, with a ceiling value of $4,433.73 and a completion date of December 17, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $10,717.42 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,518.23 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 15, 2025 and was awarded on January 14, 2025. It is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999...